Danai Dima

45PUBLICATIONS
239CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 08, 2026
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

|Jul 02, 2026
Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

|Jun 29, 2026
Healthcare resource utilization and costs in patients with multiple myeloma administered ciltacabtagene autoleucel in outpatient versus inpatient settings after one to three prior lines of therapy.

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

|Aug 28, 2025
Safety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia.

Gliceida M Galarza Fortuna, Lauren Peres, Elena Nazarenko

|Aug 01, 2025
Comprehensive assessment of adverse event profiles associated with bispecific antibodies in multiple myeloma.

Mobina Golmohammadi, Shahzad Raza, Maram Albayyadhi

Pageof 8

Frequent Collaborators

18 joint publications

Jack Khouri

15 joint publications

James A Davis

14 joint publications

Surbhi Sidana

13 joint publications

Faiz Anwer